16:19 EDT Enlivex Therapeutics (ENLV) files to sell 23.33M ordinary shares for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENLV:
- Enlivex Secures Danish Approval for Global Phase 2b Trial of Allocetra in Knee Osteoarthritis
- Enlivex receives CTA approval by DKMA for Phase 2b trial of Allocetra
- Enlivex Shares Tokenized on Ondo Global Markets to Expand Global Digital Investor Access
- Enlivex Therapeutics price target raised to $20 from $13 at H.C. Wainwright
- Enlivex Highlights Rain’s AI Agent Launch and $5 Million Grant Program to Expand Prediction Markets